Source map — AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| CNBC | news | 60% |
| AstraZeneca | news | 60% |
| Fierce Pharma | news | 60% |
| Endpoints News | news | 60% |
| finchannel | news | 60% |
| reuters.com | news | 60% |
| Yahoo Finance | news | 60% |
| www.cnbc.com | news | 50% |
| rocketnews.com | news | 50% |
| www.biospace.com | news | 50% |